Hepatitis B, C, and E viruses in solid organ transplantation: donor and recipient perspectives. [PDF]
Khan J, Kozuch J, Aslam S.
europepmc +1 more source
Review of Infections in Immunocompromised Travellers: Epidemiology, Infection Prevention and Management. [PDF]
Duduveche AE +2 more
europepmc +1 more source
Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK [PDF]
Alderton, W K +3 more
core +1 more source
ABSTRACT Objective To estimate vaccination coverage (VC) and analyze the factors associated with the incomplete vaccination schedule (IVS) in children under 5 years of age in two Basic Health Units in the Federal District of Brazil. Design A crossâsectional study.
Ivea Rayane Mendes Nicacio Viana +1 more
wiley +1 more source
Impact of demographic factors and HIV status on Hepatitis B vaccination adherence and completion rate among high-risk populations in Lagos State, Nigeria. [PDF]
Shoyemi E +5 more
europepmc +1 more source
Cold-adapted influenza viruses as a promising platform for viral-vector vaccines
I. Isakova-Sivak +2 more
semanticscholar +1 more source
Is There an Ethical Dilemma in Xenotransplantation?
ABSTRACT As clinical trials in xenotransplantation commence, the question of whether participants may withdraw from research is being intensely debated. Some authors argue that xenotransplant recipients should be subject to lifelong monitoring because of the potential risk of zoonotic or xenozoonotic infections affecting third parties.
Joachim Denner
wiley +1 more source
From Immunization to Autoimmunity: A Deep Dive Into Post-COVID-19 Vaccine Reactions-A Narrative Review. [PDF]
Yousefi-Hashemabad MJ +6 more
europepmc +1 more source
Dengue Viral Infection and Associated Liver Disease. [PDF]
Da Silva Santiago M, Wu GY.
europepmc +1 more source
Fiber-2, not Fiber-1, is the principal protective immunogen of fowl adenovirus serotype 4: insights from a comparative efficacy study of chimeric virus-based inactivated vaccines. [PDF]
Yang P +14 more
europepmc +1 more source

